Steroid Receptor RNA Activator (SRA1): Unusual Bifaceted Gene Products with Suspected Relevance to Breast Cancer
Open Access
- 1 January 2007
- journal article
- review article
- Published by SAGE Publications in Nuclear Receptor Signaling
- Vol. 5 (1) , e006
- https://doi.org/10.1621/nrs.05006
Abstract
The steroid receptor RNA activator (SRA) is a unique modulator of steroid receptor transcriptional activity, as it is able to mediate its coregulatory effects as a RNA molecule. Recent findings, however, have painted a more complex picture of the SRA gene (SRA1) products. Indeed, even though SRA was initially thought to be noncoding, several RNA isoforms have now been found to encode an endogenous protein (SRAP), which is well conserved among Chordata. Although the function of SRAP remains largely unknown, it has been proposed that, much like its corresponding RNA, the protein itself might regulate estrogen and androgen receptor signaling pathways. As such, data suggest that both SRA and SRAP might participate in the mechanisms underlying breast, as well as prostate tumorigenesis. This review summarizes the published literature dealing with these two faces of the SRA gene products and underscores the relevance of this bifaceted system to breast cancer development.Keywords
This publication has 75 references indexed in Scilit:
- Cis-acting determinants of asymmetric, cytoplasmic RNA transportRNA, 2007
- Kinases and protein phosphorylation as regulators of steroid hormone actionNuclear Receptor Signaling, 2007
- DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulationNucleic Acids Research, 2006
- The Expanding Cosmos of Nuclear Receptor CoactivatorsPublished by Elsevier ,2006
- Non-coding RNAs: New players in eukaryotic biologyPublished by Elsevier ,2005
- SRA coactivation of estrogen receptor-α is phosphorylation-independent, and enhances 4-hydroxytamoxifen agonist activityBiochemical and Biophysical Research Communications, 2004
- A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor α coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRAThe EMBO Journal, 2001
- Tamoxifen for the prevention of breast cancerEuropean Journal Of Cancer, 2000
- Agonistic Effect of Tamoxifen Is Dependent on Cell Type, ERE-Promoter Context, and Estrogen Receptor Subtype: Functional Difference between Estrogen Receptors α and βBiochemical and Biophysical Research Communications, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996